Key Stem Cells Market Players:
- Stemedica Cell Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pluristem Therapeutics Inc.
- Thermo Fisher Scientific
- Becton, Dickinson and Company
- Advanced Cell Technology Inc.
- Cellular Engineering Technologies Inc.
- CellGenix GmbH
- PromoCell GmbH
- Kite Pharma
- Genea Biocells
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of stem cells is evaluated at USD 19.47 billion.
The stem cells market size was valued at USD 19.47 billion in 2026 and is projected to reach USD 64.36 billion by the end of 2036, rising at a CAGR of 12.7% during the forecast period, i.e., 2027-2036.
North America is projected to capture 39% share of the stem cells market by the end of 2036, attributed to rising awareness about stem cell potential, increasing prevalence of chronic diseases such as diabetes, technological advancements, and favorable reimbursement policies.
Key players in the market include DuPont de Nemours, Inc., BASF SE, Novozymes A/S, Lonza Group Ltd., Royal DSM Lockheed Martin, Codexis, Inc., AB Enzymes, Sapporo Enzyme Co., Ltd., Dyadic International, Inc., Soufflet Group.
